2011
DOI: 10.1016/j.fertnstert.2010.05.026
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
1
3

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 28 publications
(106 reference statements)
0
12
1
3
Order By: Relevance
“…55 Riskli hastalarda bunlarla OHSS riskinin azaldığını gösteren yeterli veri ise henüz yoktur. 56,57 Cihan ÇETİN ve ark.…”
Section: Ohss Için Yüksek Riskli Olanlarunclassified
“…55 Riskli hastalarda bunlarla OHSS riskinin azaldığını gösteren yeterli veri ise henüz yoktur. 56,57 Cihan ÇETİN ve ark.…”
Section: Ohss Için Yüksek Riskli Olanlarunclassified
“…Further potential indications concern the prevention and therapy of a severe ovarian hyperstimulation syndrome [117], despite the fact that the data situation is quite controversial and that two additional systematic reviews could prove no or at most a marginal effect on the incidence rate of ovarian hyperstimulation syndrome [48,108]. Furthermore, deleterious effects (e.g.…”
Section: Human Albuminmentioning
confidence: 99%
“…A lot of preventive strategies have been accessed targeting different points in OHSS pathophysiologic cascade to lower the incidence and the severity of OHSS including cycle cancellation [10] , coasting [11] , freeze all [10,15] , intravenous fluids infusion as calcium infusion [12] , albumin [13] , hydroxyethyl starch [14] , replacing HCG triggering by GnRH agonist in antagonist protocol [15] , utilizing antagonist protocol in risky ART population of OHSS instead of classic agonist protocol [8] as well as replacing against by antagonist during COH if there is anticipated hyper-response [16] and dopamine agonist as cabergoline [9,17,18] . However, all these evaluated strategies did not wholly eliminate OHSS especially after HCG administration in the course of COH in context of ART cycles.…”
Section: Introductionmentioning
confidence: 99%
“…However, all these evaluated strategies did not wholly eliminate OHSS especially after HCG administration in the course of COH in context of ART cycles. There were trials assessing clinical usefulness of cabergoline and calcium infusion against placebo [9,13,14] as well as trials comparing cabergoline versus albumin infusion [20,21] , coasting [22] , calcium infusion [23] , however, the study could not found trials evaluating the interaction effect of adding cabergoline to calcium infusion in preventing OHSS. This trial aimed at exploring the value of adding oral cabergoline to calcium infusion to avoid OHSS in context of ART cycles in women at high risk for OHSS development.…”
Section: Introductionmentioning
confidence: 99%